chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; vomiting; skin lesions erupted, described as hive-like on multiple parts of the body; felt awful; the site of vaccination blistered and got about 1.5 inches around; migraine headache which lasted for about 4 weeks; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (the site of vaccination blistered and got about 1.5 inches around), MIGRAINE (migraine headache which lasted for about 4 weeks), DIARRHEA (diarrhea), VOMITING (vomiting) and SKIN LESION (skin lesions erupted, described as hive-like on multiple parts of the body) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history information was added by the reporter.  Concomitant products included LEVOTHYROXINE, FLUOXETINE, SULFASALAZINE, OXYBUTYNIN, CLOPIDOGREL, DULOXETINE, PRAVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), TOPIRAMATE, ZOLPIDEM TARTRATE (ZOLPIDEM [ZOLPIDEM TARTRATE]), GABAPENTIN, CLONAZEPAM, HYDROXYZINE, SALBUTAMOL (ALBUTEROL HFA) and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE VESICLES (the site of vaccination blistered and got about 1.5 inches around) and MIGRAINE (migraine headache which lasted for about 4 weeks). On an unknown date, the patient experienced DIARRHEA (diarrhea), VOMITING (vomiting), SKIN LESION (skin lesions erupted, described as hive-like on multiple parts of the body) and FEELING ABNORMAL (felt awful). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 15-Apr-2021, MIGRAINE (migraine headache which lasted for about 4 weeks) had resolved. At the time of the report, VACCINATION SITE VESICLES (the site of vaccination blistered and got about 1.5 inches around), DIARRHEA (diarrhea), VOMITING (vomiting), SKIN LESION (skin lesions erupted, described as hive-like on multiple parts of the body) and FEELING ABNORMAL (felt awful) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient  seen by a dermatologist and was given a steroid shot.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: The additional Email document received on 03-JUN-2021. No new information is added.
finding difficulty in walk; arm hurt very badly; she started having fever; chills; body ache; headache; joint pain; very tired with legs; arm joints very painful; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills) and MYALGIA (body ache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills), MYALGIA (body ache), HEADACHE (headache), ARTHRALGIA (joint pain), FATIGUE (very tired with legs) and ARTHRALGIA (arm joints very painful). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (finding difficulty in walk), PAIN IN EXTREMITY (arm hurt very badly), PYREXIA (she started having fever), CHILLS (chills), MYALGIA (body ache), HEADACHE (headache), ARTHRALGIA (joint pain), FATIGUE (very tired with legs) and ARTHRALGIA (arm joints very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had hormonal replacement treatment that are progesterone and estrogen.
Vaccine was mixed with wrong diluent-  Sterile Diluent/sterile water intended for live virus vaccines.  Lot# W035896  Exp 6/23/25  Manufactured by Merck and Company; dose 0.5 ml
Patient with history of ovarian cyst and endometrial atypia..  gets yearly exams. This year in February, mass has grown significantly from previous years.  From 6cm to 20cm. Possible ovarian cancer.  Also leg swelling has increased
Within about 18 hours of receiving the shot:  Hives on scalp, ears, eyelids, throat/neck, chest, hips, back, legs, wrists.  Swollen eyelids.  Chills.  Treatment:  Patient took Benadryl and used Benadryl cream before seeing the doctor (recommended by the advice nurse.)  The doctor recommended that the patient take Claritin, and the patient took the generic equivalent (Loratadine).  The treatment temporarily eased some of the itching, and the hives appeared to flatten out and spread in diameter.   As of 11/30/03: Hives are still present, large, and are even darker pink than before.
seen by MD 3DEC92 w/ 10.5 cm x 10cm warmth of lt arm, sl edema w/tenderness w/1 cm tender lt ax node; dx cellulitis;
This spontaneous report was received from a physician and refers to a 8 year old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. On 25-JUL-2017, the patient was vaccinated with a first dose of GARDASIL 9 lot # M040412, expiration date 30-JUN-2019, (route and dose were not reported) for prophylaxis. Information regarding concomitant therapies was not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Information has been received from a health professional concerning a female teenager who in April 2008 (reported as a "month ago") was vaccinated intramuscularly with a first dose of GARDASIL (Lot # not reported).  Within 24-48 hours of vaccination, the patient experienced nausea, dizziness and feeling faint for a day.  Therapy with GARDASIL was discontinued, as her mother refused to allow her to receive the second and third doses.  The patient sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/13/2008. No additional information is expected.
pt had a positive COVID test on 9/1/2021, ordered by Health Department; pt died at home with COD being COVID 19; DC and record from medical examiner sent to vaers
Starting 11/01/2021, I started having a lot of diarrhea and I started to take over the counter medication to alleviate the symptoms. After a while of it not working, I saw my gastroenterologist and they suggested I take PEPTO-BISMOL which didn't help. I had lab work done to check for infections of the GI tract and then had to do a Colonoscopy. I was diagnosed with Lymphocytic Colitis. We tried PEPTO-BISMOL which still didn't work. So, I was given a steroid (budesonide) to help and that alleviated the symptoms. I am still taking it to this day and will continue taking it for the foreseeable future. It is not a cheap medicine. Between the stool sample and the colonoscopy, I contracted COVID-19.
05/12 I began having runny nose. Had two music rehearsals the evening of the 12th. My wife recommended I take an at home test due to medication not helping runny nose that I thought was allergies. 05/13 called PCP I was advised on all the steps I needed and prescribed Paxlovid. I was also advised to stop taking cholesterol meds while on Paxlovid. Began the Paxlovid on Friday at 2. On Saturday I began feeling positive effects of the med. On Tuesday the 17th I would say that I am 70% recovered. Get fatigued very easy.
I have developed an extensive rash on both of my lower legs. It?s on the calves. Stings a little, not raised, looks darker than yesterday  in areas. Started 15 days after my booster shot (10/9). First shot on 3/19 and second on 4/9
This spontaneous report was received from a nurse, referring to an unspecified number of patients of unknown genders and ages. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of GARDASIL 9 with Lot # M037770 and an expiration date of 01-JUN-2019 (strength, dose and route were not reported) for prophylaxis. It was confirmed that all the vaccines were reconstituted with sterile diluent (lot # and expiration date were not reported) which was stored in correct temperature range. No adverse effects were reported. It was reported that the vaccines were exposed to temperature of 47 Fahrenheit degrees (°F) to 77°F range, for a time frame of 3 hours and 30 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA002379: US-009507513-1705USA000300.
Had COVID Sept 27 (positive test), with ED visit on 10/4/20, and ED/Hospitalization 10/8-12--/20, with extra quarantine from 10/8 /20 to 10/18/20.   Initially 6 hrs post 1st dose: Chills, fever (102.5 deg F), aches, weakness, chills, malaise, for next 30-32 hours  After second dose: post 5-6 hours: Chills, fever (100.2 deg F), aches, weakness, chills, malaise, for next 22-24 hours  About a week post first dose: Extremely swollen neck Lymph nodes on both sides Multiple phone calls to PCP, with a office visits on 1/19/20, and again on 2/11/21. Nodes in neck were swollen even larger on second visit.
hasn't felt very well; a knot on the arm which is swollen and red; a knot on the arm which is swollen; a knot on the arm which is swollen and red; a real bad headache; a fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (hasn't felt very well), SKIN MASS (a knot on the arm which is swollen and red), PERIPHERAL SWELLING (a knot on the arm which is swollen), ERYTHEMA (a knot on the arm which is swollen and red) and HEADACHE (a real bad headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (hasn't felt very well), SKIN MASS (a knot on the arm which is swollen and red), PERIPHERAL SWELLING (a knot on the arm which is swollen), ERYTHEMA (a knot on the arm which is swollen and red), HEADACHE (a real bad headache) and PYREXIA (a fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MALAISE (hasn't felt very well), SKIN MASS (a knot on the arm which is swollen and red), PERIPHERAL SWELLING (a knot on the arm which is swollen), ERYTHEMA (a knot on the arm which is swollen and red), HEADACHE (a real bad headache) and PYREXIA (a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. Patient had a Flu shot on her right arm.   Reporter did not allow further contact
After receiving J & J Covid vaccine, client stated she felt weak and dizzy.  After sitting for a few minutes, assisted client to lie down on couch.  Client was diaphoretic.  BP 88/68.  Legs elevated and given a few sips of juice.  BP rechecked at 100/70.  Client was well enough to transfer to observation area.  Client waited another 15 minutes and left on her own with no further complaints.
Myocarditis; Pleuritic Chest Pain; Difficulty breathing; Myalgia; Headache; Flu-like symptoms; This is a spontaneous report from a contactable physician. A 38-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 01May2021 as second dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2, on an unknown date, for COVID-19 immunization. The patient experienced myocarditis on 05May2021, and in May2021 (reported as started 2 and a half days after receiving the second dose) experienced pleuritic chest pain, difficulty breathing, myalgia, headache, and flu-like symptoms. The patient was hospitalized for the events from 05May2021 to an unknown date. The reporter assessed the events as life-threatening. The adverse events required a visit to Emergency Room. The reporter assessed that the patient's events were caused by the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.; Sender's Comments: Based on the limited information currently available, a possible association of the suspect drug administration with the reported events cannot be excluded, due to a plausible temporal relationship. This case will be reassessed when additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
This spontaneous report as received from a consumer refers to a female patient of unknown age who reported on herself. The patient's current medical history included asthma, gastrooesophageal reflux disease (GERD), fish allergy, primary hyperthyroid, sulfa and narcotics allergy. On an unknown date the patient was vaccinated with PNEUMOVAX23 (dose, route, lot number and expiration date not provided). Concomitant therapies included fluticasone propionate, ADVAIR and cetirizine hydrochloride reported as generic ZYRTEC (manufacturer unknown). The patient reported that she received a vaccine to prevent pneumonia, possibly PNEUMOVAX23. She did not recall in which arm she received the shot, but the arm blew up and was enlarging past her elbow. It lasted for more than one day. The patient was treated with BENADRYL. Lab diagnostic studies included blood work (results not provided). The patient sought medical attention via calling physician. She also recalled having an unspecified tetanus shot at a previous unspecified time where the same reaction occurred. The outcome of arm blew up and was enlarging past her elbow was reported as recovered/resolved. Additional information has been requested.
My sodium dropped to 126 on June 19th and I was hospitalised with hyponatremia. I?ve never experienced this problem before.
I tested positive for COVID 8 days after my first dose.; I tested positive for COVID 8 days after my first dose.; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date in Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got his first dose of Pfizer COVID 19 vaccine 21 days ago in Dec2020. He mentioned that he tested positive for COVID 8 days after his first dose in Dec2020. He stated that he got the second dose yesterday (unspecified date) and queried if should he not have gotten it. The outcome of the events was unknown.  Information about Lot/batch number has been requested.
Patient complained of dizziness about 5 minutes post-injection. Patient then went very pale, started perspiring profusely, and complained of nausea. Constantly remarked that she was "feeling weird and different." After drinking some cold water and sitting for ~ 30 minutes, the episode passed.
Several hours after administration of Afluria injectable vaccine, pt had complaints of LUE pain that radiated from arm to neck, rated as a 9/10. Pt was taken to a local ED for evaluation.
18 hrs p/vax pt exp high pitched non-stop crying for 8 hrs; t99-100; would not eat or sleep;
This spontaneous report as received from a Nurse refers to multiple unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported. On multiple unspecified dates the patients were vaccinated with improperly stored VARIVAX (Merck) (lot # L024256, expiry date 01-JUL-2017) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. No product quality complaint was reported. No insertion and removal event was reported. The action taken with the suspect therapy and outcome of the events was unknown. This is one of the two reports from the same source. Additional information has been requested.
Bright red cheeks the morning after vaccines given. Rash spread to trunk, then to arms and legs. Rash itchy at first, but not when evaluated by me on 07/17/08. Low-grade fever and joint aches associated with the rash. Rash blanches and is lacy. Looks like 5th disease.
This spontaneous report was received from a certified medical assistant referring to unknown age and gender patient. No information regarding the patients' medical history, concurrent conditions and concomitant medications were not provided. On 29-JUL-2016 the patient was vaccinates with improperly stored GARDASIL 9 (dose and route of administration were not reported); (lot no. M003659 EXP 20-SEP-2017 or lot no. L025737 EXP 28-JUL-2017). No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Macular edema affecting central vision, headaches. Will follow up with Retina specialist in January 2022
Information has been received from a registered nurse concerning a 61 year old patient who on 12-NOV-2010 was vaccinated with a dose of VARIVAX (Merck) (lot number 666854/0163Z) instead of ZOSTAVAX (Merck) due to a human error. There was no adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Patient reported redness around injection site 2 inches in diameter that appeared the day after injection. She has been diagnosed by physician with cellulitis and is currently on her second course of antibiotics and topical therapy. As of 5/11/13, she still reports that her condition has not resolved.
28 patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (28 patient received expired vaccine) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (28 patient received expired vaccine). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (28 patient received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
lightheaded, nauseous, feeling faint. Manual BP was taken as automatic BP was unable to be obtained; manual BP was 80/52 mmHg. Water provided, cold pack applied to  posterior neck. Patient recovered after 13 minutes and was walked out of building by RN.
OVAL SHAPED RAISED REDDISH AREA  12.5 CM BY 8 CM
Initial report received from a health care professional on 03 October 2007. A 64-year-old female patient with a medical history of a doxycycline allergy complained of dizziness, vertigo, headache, hives, heart palpitations, shakiness and weakness two to three days after she had received an intramuscular left deltoid injection of FLUZONE, lot number U2454AA. The reporter stated that the patient was "feeling a little sick" at the time of vaccination. It was unknown if the patient had received any vaccinations during the four weeks prior to vaccination or if the patient had been taking any concomitant medications. The patient was not evalutated by their physician and corrective treatments had not been reported. The patient had not experienced any adverse events following receipt of prior doses of FLUZONE. The patient's recovery status was listed as not recovered at the time of the report. Follow-up informatio was received from a health care professional on 07 January 2008. According to the reporter, they reviewed the case and had no additional information to provide at this time. The patient's recovery status remained as not recovered fromthe event. The reporting facility in this case is the same as in case 2007-03356.
Patient came into pharmacy to show her right upper arm had rash/bruising which she stated was hot to the touch and had developed just this morning 1/15/19.  She had received the two vaccinations Pneumo23 and SHINGRIX (2nd dose) 7 days earlier on 1/8/19. Patient stated no other symptoms and was told by RPh to apply cold compresses and take OTC analgesics as needed.
Pt recvd 3 doses of Engerix-B 19MAR90, 13APR90, 06SEP90 & it was determined that pt failed to seroconvert;